L’incidence du rôle d’infirmière clinicienne spécialisée dans le programme des néoplasies myéloprolifératives : Deuxième partie – L’expérience des soins des patients et de l’équipe Article Swipe
Verna Cheung
,
Melanie Powis
,
Jaime O. Claudio
,
Gustav Lindberg
,
Andrea Arruda
,
Cristina Emanuele
,
Taylor Nye
,
Marta B. Davidson
,
Aniket Bankar
,
Hassan Sibai
,
Vikas Gupta
,
Dawn Maze
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.5737/2368807635180
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.5737/2368807635180
Les néoplasies myéloprolifératives forment un groupe de troubles clonaux rares des cellules progénitrices hématopoïétiques; elles sont associées à des symptômes propres à la maladie, à des événements thrombotiques et à un risque d’évolution vers la leucémie myéloblastique aiguë (Tefferi, 2021). La relative rareté de cette pathologie ainsi que la complexité des soins ont mené à la création du programme des néoplasies myéloprolifératives du Centre de cancérologie Princess Margaret. Le programme applique un modèle de soins partagés avec des hématologues de la région (qui deviennent partenaires des soins partagés) pour assurer aux patients l’accès à un spécialiste des néoplasies myéloprolifératives tout en continuant de recevoir des soins près de chez eux (Cheung et al., 2021). En place depuis 2016, le rôle d’infirmière clinicienne spécialisée (ICS) a fait son apparition non seulement pour appuyer le modèle de soins partagés, mais aussi pour faciliter le triage des patients nouvellement aiguillés vers le centre, et faciliter les consultations et le suivi. Bien que ce rôle fasse partie du système de santé depuis les années 1940, sa définition et ses avantages demeurent parfois flous pour l’équipe interdisciplinaire. La série d’articles décrit, à l’aide d’une approche multiméthode, le processus et les résultats quantitatifs de l’évaluation des effets du rôle d’ICS sur le programme des néoplasies myéloprolifératives. Cette seconde partie traite de l’expérience des soins que font les patients et les soignants de la présence de l’ICS au sein de l’équipe de professionnels. Mots-clés : infirmière clinicienne spécialisée, influence du rôle, économie de coûts
Related Topics
Concepts
Metadata
- Type
- article
- Language
- fr
- Landing Page
- https://doi.org/10.5737/2368807635180
- https://canadianoncologynursingjournal.com/index.php/conj/article/download/1555/1248
- OA Status
- diamond
- References
- 24
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4407947775
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4407947775Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.5737/2368807635180Digital Object Identifier
- Title
-
L’incidence du rôle d’infirmière clinicienne spécialisée dans le programme des néoplasies myéloprolifératives : Deuxième partie – L’expérience des soins des patients et de l’équipeWork title
- Type
-
articleOpenAlex work type
- Language
-
frPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-02-24Full publication date if available
- Authors
-
Verna Cheung, Melanie Powis, Jaime O. Claudio, Gustav Lindberg, Andrea Arruda, Cristina Emanuele, Taylor Nye, Marta B. Davidson, Aniket Bankar, Hassan Sibai, Vikas Gupta, Dawn MazeList of authors in order
- Landing page
-
https://doi.org/10.5737/2368807635180Publisher landing page
- PDF URL
-
https://canadianoncologynursingjournal.com/index.php/conj/article/download/1555/1248Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://canadianoncologynursingjournal.com/index.php/conj/article/download/1555/1248Direct OA link when available
- Concepts
-
Humanities, Medicine, Political science, ArtTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
24Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4407947775 |
|---|---|
| doi | https://doi.org/10.5737/2368807635180 |
| ids.doi | https://doi.org/10.5737/2368807635180 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40874099 |
| ids.openalex | https://openalex.org/W4407947775 |
| fwci | 0.0 |
| type | article |
| title | L’incidence du rôle d’infirmière clinicienne spécialisée dans le programme des néoplasies myéloprolifératives : Deuxième partie – L’expérience des soins des patients et de l’équipe |
| biblio.issue | 1 |
| biblio.volume | 35 |
| biblio.last_page | 88 |
| biblio.first_page | 80 |
| topics[0].id | https://openalex.org/T12246 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9940000176429749 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Chronic Disease Management Strategies |
| topics[1].id | https://openalex.org/T11628 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9785000085830688 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2716 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Myeloproliferative Neoplasms: Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T14186 |
| topics[2].field.id | https://openalex.org/fields/36 |
| topics[2].field.display_name | Health Professions |
| topics[2].score | 0.9672999978065491 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3600 |
| topics[2].subfield.display_name | General Health Professions |
| topics[2].display_name | Healthcare Systems and Practices |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C15708023 |
| concepts[0].level | 1 |
| concepts[0].score | 0.6713554859161377 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q80083 |
| concepts[0].display_name | Humanities |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.43188321590423584 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C17744445 |
| concepts[2].level | 0 |
| concepts[2].score | 0.4167730212211609 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[2].display_name | Political science |
| concepts[3].id | https://openalex.org/C142362112 |
| concepts[3].level | 0 |
| concepts[3].score | 0.31550073623657227 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q735 |
| concepts[3].display_name | Art |
| keywords[0].id | https://openalex.org/keywords/humanities |
| keywords[0].score | 0.6713554859161377 |
| keywords[0].display_name | Humanities |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.43188321590423584 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/political-science |
| keywords[2].score | 0.4167730212211609 |
| keywords[2].display_name | Political science |
| keywords[3].id | https://openalex.org/keywords/art |
| keywords[3].score | 0.31550073623657227 |
| keywords[3].display_name | Art |
| language | fr |
| locations[0].id | doi:10.5737/2368807635180 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210172061 |
| locations[0].source.issn | 1181-912X, 2368-8076 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1181-912X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Canadian Oncology Nursing Journal |
| locations[0].source.host_organization | https://openalex.org/P4310312932 |
| locations[0].source.host_organization_name | Pappin Communications |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310312932 |
| locations[0].license | |
| locations[0].pdf_url | https://canadianoncologynursingjournal.com/index.php/conj/article/download/1555/1248 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Canadian Oncology Nursing Journal |
| locations[0].landing_page_url | https://doi.org/10.5737/2368807635180 |
| locations[1].id | pmid:40874099 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Canadian oncology nursing journal = Revue canadienne de nursing oncologique |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40874099 |
| locations[2].id | pmh:oai:europepmc.org:11188424 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12379920 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5019627044 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-4921-8102 |
| authorships[0].author.display_name | Verna Cheung |
| authorships[0].countries | CA, US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1299907687, https://openalex.org/I185261750, https://openalex.org/I2802654988 |
| authorships[0].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret; Faculté de sciences infirmières Lawrence S. Bloomberg, Université de Toronto. |
| authorships[0].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[0].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[0].institutions[0].country_code | CA |
| authorships[0].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[0].institutions[1].id | https://openalex.org/I185261750 |
| authorships[0].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[0].institutions[1].country_code | CA |
| authorships[0].institutions[1].display_name | University of Toronto |
| authorships[0].institutions[2].id | https://openalex.org/I1299907687 |
| authorships[0].institutions[2].ror | https://ror.org/02rdpzb15 |
| authorships[0].institutions[2].type | company |
| authorships[0].institutions[2].lineage | https://openalex.org/I1299907687 |
| authorships[0].institutions[2].country_code | US |
| authorships[0].institutions[2].display_name | Bloomberg (United States) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Verna Cheung |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Centre de cancérologie Princess Margaret; Faculté de sciences infirmières Lawrence S. Bloomberg, Université de Toronto. |
| authorships[1].author.id | https://openalex.org/A5044921674 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6038-0701 |
| authorships[1].author.display_name | Melanie Powis |
| authorships[1].countries | CA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2802654988 |
| authorships[1].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret. |
| authorships[1].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[1].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[1].institutions[0].country_code | CA |
| authorships[1].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Melanie Powis |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Centre de cancérologie Princess Margaret. |
| authorships[2].author.id | https://openalex.org/A5113631139 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Jaime O. Claudio |
| authorships[2].countries | CA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2802654988 |
| authorships[2].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret. |
| authorships[2].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[2].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[2].institutions[0].country_code | CA |
| authorships[2].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jaime O Claudio |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Centre de cancérologie Princess Margaret. |
| authorships[3].author.id | https://openalex.org/A5076759981 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Gustav Lindberg |
| authorships[3].countries | CA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2802654988 |
| authorships[3].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret. |
| authorships[3].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[3].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[3].institutions[0].country_code | CA |
| authorships[3].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Greg Lindberg |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Centre de cancérologie Princess Margaret. |
| authorships[4].author.id | https://openalex.org/A5083780768 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2516-8005 |
| authorships[4].author.display_name | Andrea Arruda |
| authorships[4].countries | CA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2802654988 |
| authorships[4].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret. |
| authorships[4].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[4].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[4].institutions[0].country_code | CA |
| authorships[4].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Andrea Arruda |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Centre de cancérologie Princess Margaret. |
| authorships[5].author.id | https://openalex.org/A5090304334 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Cristina Emanuele |
| authorships[5].countries | CA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2802654988 |
| authorships[5].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret. |
| authorships[5].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[5].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[5].institutions[0].country_code | CA |
| authorships[5].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Cristina Emanuele |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Centre de cancérologie Princess Margaret. |
| authorships[6].author.id | https://openalex.org/A5060001390 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Taylor Nye |
| authorships[6].countries | CA |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2802654988 |
| authorships[6].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret. |
| authorships[6].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[6].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[6].institutions[0].country_code | CA |
| authorships[6].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Taylor Nye |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Centre de cancérologie Princess Margaret. |
| authorships[7].author.id | https://openalex.org/A5019264272 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-6978-1368 |
| authorships[7].author.display_name | Marta B. Davidson |
| authorships[7].countries | CA |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I185261750, https://openalex.org/I2802654988 |
| authorships[7].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret; Université de Toronto. |
| authorships[7].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[7].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[7].institutions[0].country_code | CA |
| authorships[7].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[7].institutions[1].id | https://openalex.org/I185261750 |
| authorships[7].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[7].institutions[1].type | education |
| authorships[7].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[7].institutions[1].country_code | CA |
| authorships[7].institutions[1].display_name | University of Toronto |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Marta Davidson |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Centre de cancérologie Princess Margaret; Université de Toronto. |
| authorships[8].author.id | https://openalex.org/A5010559518 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-0140-0538 |
| authorships[8].author.display_name | Aniket Bankar |
| authorships[8].countries | CA |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I185261750, https://openalex.org/I2802654988 |
| authorships[8].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret; Université de Toronto. |
| authorships[8].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[8].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[8].institutions[0].country_code | CA |
| authorships[8].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[8].institutions[1].id | https://openalex.org/I185261750 |
| authorships[8].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[8].institutions[1].country_code | CA |
| authorships[8].institutions[1].display_name | University of Toronto |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Aniket Bankar |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Centre de cancérologie Princess Margaret; Université de Toronto. |
| authorships[9].author.id | https://openalex.org/A5048157762 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-9030-8583 |
| authorships[9].author.display_name | Hassan Sibai |
| authorships[9].countries | CA |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I185261750, https://openalex.org/I2802654988 |
| authorships[9].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret; Université de Toronto. |
| authorships[9].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[9].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[9].institutions[0].country_code | CA |
| authorships[9].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[9].institutions[1].id | https://openalex.org/I185261750 |
| authorships[9].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[9].institutions[1].type | education |
| authorships[9].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[9].institutions[1].country_code | CA |
| authorships[9].institutions[1].display_name | University of Toronto |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Hassan Sibai |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Centre de cancérologie Princess Margaret; Université de Toronto. |
| authorships[10].author.id | https://openalex.org/A5067214379 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-1419-8607 |
| authorships[10].author.display_name | Vikas Gupta |
| authorships[10].countries | CA |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I185261750, https://openalex.org/I2802654988 |
| authorships[10].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret; Université de Toronto. |
| authorships[10].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[10].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[10].institutions[0].country_code | CA |
| authorships[10].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[10].institutions[1].id | https://openalex.org/I185261750 |
| authorships[10].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[10].institutions[1].country_code | CA |
| authorships[10].institutions[1].display_name | University of Toronto |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Vikas Gupta |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Centre de cancérologie Princess Margaret; Université de Toronto. |
| authorships[11].author.id | https://openalex.org/A5085305707 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-4598-9380 |
| authorships[11].author.display_name | Dawn Maze |
| authorships[11].countries | CA |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I185261750, https://openalex.org/I2802654988 |
| authorships[11].affiliations[0].raw_affiliation_string | Centre de cancérologie Princess Margaret; Université de Toronto. |
| authorships[11].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[11].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[11].institutions[0].country_code | CA |
| authorships[11].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[11].institutions[1].id | https://openalex.org/I185261750 |
| authorships[11].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[11].institutions[1].type | education |
| authorships[11].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[11].institutions[1].country_code | CA |
| authorships[11].institutions[1].display_name | University of Toronto |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Dawn Maze |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Centre de cancérologie Princess Margaret; Université de Toronto. |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://canadianoncologynursingjournal.com/index.php/conj/article/download/1555/1248 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-02-27T00:00:00 |
| display_name | L’incidence du rôle d’infirmière clinicienne spécialisée dans le programme des néoplasies myéloprolifératives : Deuxième partie – L’expérience des soins des patients et de l’équipe |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12246 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9940000176429749 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Chronic Disease Management Strategies |
| related_works | https://openalex.org/W3183948672, https://openalex.org/W3173606202, https://openalex.org/W3110381201, https://openalex.org/W2948807893, https://openalex.org/W2899084033, https://openalex.org/W2778153218, https://openalex.org/W2758277628, https://openalex.org/W2748952813, https://openalex.org/W1531601525, https://openalex.org/W4391375266 |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.5737/2368807635180 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210172061 |
| best_oa_location.source.issn | 1181-912X, 2368-8076 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1181-912X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Canadian Oncology Nursing Journal |
| best_oa_location.source.host_organization | https://openalex.org/P4310312932 |
| best_oa_location.source.host_organization_name | Pappin Communications |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310312932 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://canadianoncologynursingjournal.com/index.php/conj/article/download/1555/1248 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Canadian Oncology Nursing Journal |
| best_oa_location.landing_page_url | https://doi.org/10.5737/2368807635180 |
| primary_location.id | doi:10.5737/2368807635180 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210172061 |
| primary_location.source.issn | 1181-912X, 2368-8076 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1181-912X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Canadian Oncology Nursing Journal |
| primary_location.source.host_organization | https://openalex.org/P4310312932 |
| primary_location.source.host_organization_name | Pappin Communications |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310312932 |
| primary_location.license | |
| primary_location.pdf_url | https://canadianoncologynursingjournal.com/index.php/conj/article/download/1555/1248 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Canadian Oncology Nursing Journal |
| primary_location.landing_page_url | https://doi.org/10.5737/2368807635180 |
| publication_date | 2025-02-24 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2002128751, https://openalex.org/W2097028250, https://openalex.org/W3105658552, https://openalex.org/W2073344502, https://openalex.org/W2206636985, https://openalex.org/W4285794526, https://openalex.org/W2971465540, https://openalex.org/W2354152365, https://openalex.org/W2054589325, https://openalex.org/W2064156125, https://openalex.org/W2897428258, https://openalex.org/W2069333573, https://openalex.org/W2939102549, https://openalex.org/W2170568086, https://openalex.org/W3161505483, https://openalex.org/W2010870426, https://openalex.org/W2946459895, https://openalex.org/W4322504199, https://openalex.org/W2443425514, https://openalex.org/W2116246239, https://openalex.org/W1586044552, https://openalex.org/W2588014079, https://openalex.org/W3124054271, https://openalex.org/W1990542237 |
| referenced_works_count | 24 |
| abstract_inverted_index.: | 237 |
| abstract_inverted_index.a | 124 |
| abstract_inverted_index.En | 114 |
| abstract_inverted_index.La | 40, 182 |
| abstract_inverted_index.Le | 68 |
| abstract_inverted_index.au | 230 |
| abstract_inverted_index.ce | 159 |
| abstract_inverted_index.de | 6, 43, 64, 73, 79, 102, 107, 134, 165, 197, 214, 225, 228, 232, 234, 245 |
| abstract_inverted_index.du | 57, 62, 163, 201, 242 |
| abstract_inverted_index.en | 100 |
| abstract_inverted_index.et | 28, 111, 150, 154, 173, 193, 222 |
| abstract_inverted_index.la | 22, 34, 48, 55, 80, 226 |
| abstract_inverted_index.le | 118, 132, 141, 148, 155, 191, 205 |
| abstract_inverted_index.sa | 171 |
| abstract_inverted_index.un | 4, 30, 71, 94 |
| abstract_inverted_index.à | 17, 21, 24, 29, 54, 93, 186 |
| abstract_inverted_index.Les | 0 |
| abstract_inverted_index.aux | 90 |
| abstract_inverted_index.des | 10, 18, 25, 50, 59, 77, 85, 96, 104, 143, 199, 207, 216 |
| abstract_inverted_index.eux | 109 |
| abstract_inverted_index.les | 152, 168, 194, 220, 223 |
| abstract_inverted_index.non | 128 |
| abstract_inverted_index.ont | 52 |
| abstract_inverted_index.que | 47, 158, 218 |
| abstract_inverted_index.ses | 174 |
| abstract_inverted_index.son | 126 |
| abstract_inverted_index.sur | 204 |
| abstract_inverted_index.(qui | 82 |
| abstract_inverted_index.Bien | 157 |
| abstract_inverted_index.al., | 112 |
| abstract_inverted_index.avec | 76 |
| abstract_inverted_index.chez | 108 |
| abstract_inverted_index.fait | 125 |
| abstract_inverted_index.font | 219 |
| abstract_inverted_index.mais | 137 |
| abstract_inverted_index.pour | 88, 130, 139, 179 |
| abstract_inverted_index.sein | 231 |
| abstract_inverted_index.sont | 15 |
| abstract_inverted_index.tout | 99 |
| abstract_inverted_index.vers | 33, 147 |
| abstract_inverted_index.(ICS) | 123 |
| abstract_inverted_index.1940, | 170 |
| abstract_inverted_index.2016, | 117 |
| abstract_inverted_index.Cette | 210 |
| abstract_inverted_index.ainsi | 46 |
| abstract_inverted_index.aussi | 138 |
| abstract_inverted_index.cette | 44 |
| abstract_inverted_index.elles | 14 |
| abstract_inverted_index.fasse | 161 |
| abstract_inverted_index.flous | 178 |
| abstract_inverted_index.mené | 53 |
| abstract_inverted_index.place | 115 |
| abstract_inverted_index.près | 106 |
| abstract_inverted_index.rares | 9 |
| abstract_inverted_index.rôle | 119, 160, 202 |
| abstract_inverted_index.soins | 51, 74, 86, 105, 135, 217 |
| abstract_inverted_index.2021). | 39, 113 |
| abstract_inverted_index.Centre | 63 |
| abstract_inverted_index.aiguë | 37 |
| abstract_inverted_index.coûts | 246 |
| abstract_inverted_index.depuis | 116, 167 |
| abstract_inverted_index.effets | 200 |
| abstract_inverted_index.groupe | 5 |
| abstract_inverted_index.partie | 162, 212 |
| abstract_inverted_index.risque | 31 |
| abstract_inverted_index.rôle, | 243 |
| abstract_inverted_index.santé | 166 |
| abstract_inverted_index.suivi. | 156 |
| abstract_inverted_index.série | 183 |
| abstract_inverted_index.traite | 213 |
| abstract_inverted_index.triage | 142 |
| abstract_inverted_index.(Cheung | 110 |
| abstract_inverted_index.années | 169 |
| abstract_inverted_index.appuyer | 131 |
| abstract_inverted_index.assurer | 89 |
| abstract_inverted_index.centre, | 149 |
| abstract_inverted_index.clonaux | 8 |
| abstract_inverted_index.d’ICS | 203 |
| abstract_inverted_index.d’une | 188 |
| abstract_inverted_index.forment | 3 |
| abstract_inverted_index.l’ICS | 229 |
| abstract_inverted_index.modèle | 72, 133 |
| abstract_inverted_index.parfois | 177 |
| abstract_inverted_index.propres | 20 |
| abstract_inverted_index.rareté | 42 |
| abstract_inverted_index.région | 81 |
| abstract_inverted_index.seconde | 211 |
| abstract_inverted_index.Princess | 66 |
| abstract_inverted_index.applique | 70 |
| abstract_inverted_index.approche | 189 |
| abstract_inverted_index.cellules | 11 |
| abstract_inverted_index.décrit, | 185 |
| abstract_inverted_index.l’aide | 187 |
| abstract_inverted_index.maladie, | 23 |
| abstract_inverted_index.patients | 91, 144, 221 |
| abstract_inverted_index.recevoir | 103 |
| abstract_inverted_index.relative | 41 |
| abstract_inverted_index.système | 164 |
| abstract_inverted_index.troubles | 7 |
| abstract_inverted_index.(Tefferi, | 38 |
| abstract_inverted_index.Margaret. | 67 |
| abstract_inverted_index.avantages | 175 |
| abstract_inverted_index.création | 56 |
| abstract_inverted_index.demeurent | 176 |
| abstract_inverted_index.faciliter | 140, 151 |
| abstract_inverted_index.influence | 241 |
| abstract_inverted_index.leucémie | 35 |
| abstract_inverted_index.partagés | 75 |
| abstract_inverted_index.processus | 192 |
| abstract_inverted_index.programme | 58, 69, 206 |
| abstract_inverted_index.présence | 227 |
| abstract_inverted_index.seulement | 129 |
| abstract_inverted_index.soignants | 224 |
| abstract_inverted_index.économie | 244 |
| abstract_inverted_index.Mots-clés | 236 |
| abstract_inverted_index.aiguillés | 146 |
| abstract_inverted_index.apparition | 127 |
| abstract_inverted_index.associées | 16 |
| abstract_inverted_index.continuant | 101 |
| abstract_inverted_index.deviennent | 83 |
| abstract_inverted_index.l’accès | 92 |
| abstract_inverted_index.partagés) | 87 |
| abstract_inverted_index.partagés, | 136 |
| abstract_inverted_index.pathologie | 45 |
| abstract_inverted_index.résultats | 195 |
| abstract_inverted_index.symptômes | 19 |
| abstract_inverted_index.clinicienne | 121, 239 |
| abstract_inverted_index.complexité | 49 |
| abstract_inverted_index.définition | 172 |
| abstract_inverted_index.infirmière | 238 |
| abstract_inverted_index.l’équipe | 180, 233 |
| abstract_inverted_index.néoplasies | 1, 60, 97, 208 |
| abstract_inverted_index.partenaires | 84 |
| abstract_inverted_index.d’articles | 184 |
| abstract_inverted_index.nouvellement | 145 |
| abstract_inverted_index.quantitatifs | 196 |
| abstract_inverted_index.spécialiste | 95 |
| abstract_inverted_index.événements | 26 |
| abstract_inverted_index.cancérologie | 65 |
| abstract_inverted_index.consultations | 153 |
| abstract_inverted_index.hématologues | 78 |
| abstract_inverted_index.spécialisée | 122 |
| abstract_inverted_index.thrombotiques | 27 |
| abstract_inverted_index.d’évolution | 32 |
| abstract_inverted_index.multiméthode, | 190 |
| abstract_inverted_index.progénitrices | 12 |
| abstract_inverted_index.spécialisée, | 240 |
| abstract_inverted_index.d’infirmière | 120 |
| abstract_inverted_index.l’expérience | 215 |
| abstract_inverted_index.l’évaluation | 198 |
| abstract_inverted_index.myéloblastique | 36 |
| abstract_inverted_index.professionnels. | 235 |
| abstract_inverted_index.interdisciplinaire. | 181 |
| abstract_inverted_index.hématopoïétiques; | 13 |
| abstract_inverted_index.myéloprolifératives | 2, 61, 98 |
| abstract_inverted_index.myéloprolifératives. | 209 |
| cited_by_percentile_year | |
| countries_distinct_count | 2 |
| institutions_distinct_count | 12 |
| citation_normalized_percentile.value | 0.08555069 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |